![]() |
![]() |
Canavan diseaseDefinition Canavan disease is an inherited disorder of aspartic acid metabolism. It is characterized by degeneration of the white matter of the brain. Causes, incidence, and risk factors Canavan disease is inherited as an autosomal recessive trait. It is more common among Ashkenazi Jews than in the general population. A deficient enzyme, aspartoacylase, results in the accumulation of N-acetylaspartic acid in the brain. This causes a degeneration of the white matter. Typically, symptoms begin in the first year of life. Parents tend to notice when a child is not reaching particular developmental milestones, including poor muscle tone and lack of head control. Eventually, the child can develop feeding problems, seizures, and loss of vision. Although death often occurs before 18 months of age, some live until they are teenagers or, rarely, young adults. Symptoms
Signs and tests
Treatment Treatment aims to ease the symptoms of the disease. There is no specific treatment. Support Groups Additional information and resources are available from: Canavan Foundation 877-4-CANAVAN Expectations (prognosis) With Canavan disease, the central nervous system degenerates, and progressive disability is likely. Death usually occurs in the first 1 to 2 decades of life. Complications This is often a fatal disorder and includes severe disabilities such as mental retardation, blindness, and inability to walk. Calling your health care provider Call your health care provider if your child has any symptoms of Canavan disease. Prevention Genetic counseling is recommended for prospective parents with a family history of Canavan disease and should be considered if both parents are of Ashkenazi Jewish descent. For this latter group, DNA testing can almost always tell if one or both parents is a carrier. Page Content: Spongy degeneration of the brain; Aspartoacylase deficiency |
![]() ![]() ![]() |